NEW APPOINTMENT AT SHIMADZU BIOTECH

Key role aids development of a unified solution to drug discovery and proteomics

Shimadzu Biotech, a newly formed business unit of Shimadzu Corporation, has recently appointed a new Applications Laboratory Manager to head up its applications facility housed within Kratos Analytical in Manchester. This is part of the unit's strategy to bring together products from both Shimadzu Corporation and Kratos Analytical to provide scientists with a unified solution to drug discovery and proteomics, and to develop exciting new technologies to advance research in this field.

Rachel Martin will take full responsibility for biotechnology applications in Manchester and USA, and also for the MALDI applications programme worldwide.

Shimadzu Biotech's MALDI TOF Business Manager, Frank Trundle, remarked: "Rachel's role is a key function that will assist the progress of our business development strategy, and help us achieve our objectives within the life science and drug discovery market sectors."

Rachel has extensive experience in this field, having previously carried out an international technical support function for MALDI TOF MS and robotic sample preparation technology.

- ends -

For more information, please contact:

Shimadzu Biotech
Chris Sutton, MALDI Business Manager
Fax: +44 (0)161 888 4402 ext 228
Tel: +44 (0)161 888 4400
email: chris.sutton@kratos.co.uk
Website: http://www.shimadzu-biotech.net

For press information, please contact:

HCC De Facto Group plc
Richard Anderson
Tel: +44 (0)20 7496 3300
Fax: +44 (0)20 7496 3355
email: r.anderson@hccdefacto.com